Global Phentolamine Mesylate Injection Market Growth 2026-2032
The global Phentolamine Mesylate Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Phentolamine mesylate injection is a formulation of phentolamine, a non-selective alpha-adrenergic antagonist, used primarily for the management of hypertensive episodes, particularly in patients with pheochromocytoma. This injectable preparation allows for rapid administration via intravenous or intramuscular routes, providing quick onset of action in acute situations.
United States market for Phentolamine Mesylate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Phentolamine Mesylate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Phentolamine Mesylate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Phentolamine Mesylate Injection players cover Septodont, Hikma, Precision Dose, CR Double-Crane, Sichuan Meida Kangjiale Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Phentolamine Mesylate Injection Industry Forecast” looks at past sales and reviews total world Phentolamine Mesylate Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Phentolamine Mesylate Injection sales for 2026 through 2032. With Phentolamine Mesylate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phentolamine Mesylate Injection industry.
This Insight Report provides a comprehensive analysis of the global Phentolamine Mesylate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phentolamine Mesylate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phentolamine Mesylate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phentolamine Mesylate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phentolamine Mesylate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Phentolamine Mesylate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Phentolamine Mesylate Injection market?
What factors are driving Phentolamine Mesylate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Phentolamine Mesylate Injection market opportunities vary by end market size?
How does Phentolamine Mesylate Injection break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Phentolamine mesylate injection is a formulation of phentolamine, a non-selective alpha-adrenergic antagonist, used primarily for the management of hypertensive episodes, particularly in patients with pheochromocytoma. This injectable preparation allows for rapid administration via intravenous or intramuscular routes, providing quick onset of action in acute situations.
United States market for Phentolamine Mesylate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Phentolamine Mesylate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Phentolamine Mesylate Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Phentolamine Mesylate Injection players cover Septodont, Hikma, Precision Dose, CR Double-Crane, Sichuan Meida Kangjiale Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Phentolamine Mesylate Injection Industry Forecast” looks at past sales and reviews total world Phentolamine Mesylate Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Phentolamine Mesylate Injection sales for 2026 through 2032. With Phentolamine Mesylate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phentolamine Mesylate Injection industry.
This Insight Report provides a comprehensive analysis of the global Phentolamine Mesylate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phentolamine Mesylate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phentolamine Mesylate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phentolamine Mesylate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phentolamine Mesylate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Phentolamine Mesylate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Intravenous Injection
- Intramuscular Injection
- Hospital and Clinic
- Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Septodont
- Hikma
- Precision Dose
- CR Double-Crane
- Sichuan Meida Kangjiale Pharmaceutical
- Sunflower Pharmaceutical
- Shanghai Fudan Forward Pharmaceuticals
- Hainan Poly Pharm
What is the 10-year outlook for the global Phentolamine Mesylate Injection market?
What factors are driving Phentolamine Mesylate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Phentolamine Mesylate Injection market opportunities vary by end market size?
How does Phentolamine Mesylate Injection break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Phentolamine Mesylate Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Phentolamine Mesylate Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Phentolamine Mesylate Injection by Country/Region, 2021, 2025 & 2032
2.2 Phentolamine Mesylate Injection Segment by Type
2.2.1 Intravenous Injection
2.2.2 Intramuscular Injection
2.2.3 Phentolamine Mesylate Injection Sales by Type
2.2.3.1 Global Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Phentolamine Mesylate Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Phentolamine Mesylate Injection Sale Price by Type (2021-2026)
2.3 Phentolamine Mesylate Injection Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Phentolamine Mesylate Injection Sales by Application
2.3.4.1 Global Phentolamine Mesylate Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Phentolamine Mesylate Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Phentolamine Mesylate Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Phentolamine Mesylate Injection Breakdown Data by Company
3.1.1 Global Phentolamine Mesylate Injection Annual Sales by Company (2021-2026)
3.1.2 Global Phentolamine Mesylate Injection Sales Market Share by Company (2021-2026)
3.2 Global Phentolamine Mesylate Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Phentolamine Mesylate Injection Revenue by Company (2021-2026)
3.2.2 Global Phentolamine Mesylate Injection Revenue Market Share by Company (2021-2026)
3.3 Global Phentolamine Mesylate Injection Sale Price by Company
3.4 Key Manufacturers Phentolamine Mesylate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Phentolamine Mesylate Injection Product Location Distribution
3.4.2 Players Phentolamine Mesylate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHENTOLAMINE MESYLATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Phentolamine Mesylate Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Phentolamine Mesylate Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Phentolamine Mesylate Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Phentolamine Mesylate Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Phentolamine Mesylate Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Phentolamine Mesylate Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Phentolamine Mesylate Injection Sales Growth
4.4 APAC Phentolamine Mesylate Injection Sales Growth
4.5 Europe Phentolamine Mesylate Injection Sales Growth
4.6 Middle East & Africa Phentolamine Mesylate Injection Sales Growth
5 AMERICAS
5.1 Americas Phentolamine Mesylate Injection Sales by Country
5.1.1 Americas Phentolamine Mesylate Injection Sales by Country (2021-2026)
5.1.2 Americas Phentolamine Mesylate Injection Revenue by Country (2021-2026)
5.2 Americas Phentolamine Mesylate Injection Sales by Type (2021-2026)
5.3 Americas Phentolamine Mesylate Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phentolamine Mesylate Injection Sales by Region
6.1.1 APAC Phentolamine Mesylate Injection Sales by Region (2021-2026)
6.1.2 APAC Phentolamine Mesylate Injection Revenue by Region (2021-2026)
6.2 APAC Phentolamine Mesylate Injection Sales by Type (2021-2026)
6.3 APAC Phentolamine Mesylate Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Phentolamine Mesylate Injection by Country
7.1.1 Europe Phentolamine Mesylate Injection Sales by Country (2021-2026)
7.1.2 Europe Phentolamine Mesylate Injection Revenue by Country (2021-2026)
7.2 Europe Phentolamine Mesylate Injection Sales by Type (2021-2026)
7.3 Europe Phentolamine Mesylate Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Phentolamine Mesylate Injection by Country
8.1.1 Middle East & Africa Phentolamine Mesylate Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Phentolamine Mesylate Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Phentolamine Mesylate Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Phentolamine Mesylate Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Phentolamine Mesylate Injection
10.3 Manufacturing Process Analysis of Phentolamine Mesylate Injection
10.4 Industry Chain Structure of Phentolamine Mesylate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Phentolamine Mesylate Injection Distributors
11.3 Phentolamine Mesylate Injection Customer
12 WORLD FORECAST REVIEW FOR PHENTOLAMINE MESYLATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Phentolamine Mesylate Injection Market Size Forecast by Region
12.1.1 Global Phentolamine Mesylate Injection Forecast by Region (2027-2032)
12.1.2 Global Phentolamine Mesylate Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Phentolamine Mesylate Injection Forecast by Type (2027-2032)
12.7 Global Phentolamine Mesylate Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Septodont
13.1.1 Septodont Company Information
13.1.2 Septodont Phentolamine Mesylate Injection Product Portfolios and Specifications
13.1.3 Septodont Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Septodont Main Business Overview
13.1.5 Septodont Latest Developments
13.2 Hikma
13.2.1 Hikma Company Information
13.2.2 Hikma Phentolamine Mesylate Injection Product Portfolios and Specifications
13.2.3 Hikma Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Hikma Main Business Overview
13.2.5 Hikma Latest Developments
13.3 Precision Dose
13.3.1 Precision Dose Company Information
13.3.2 Precision Dose Phentolamine Mesylate Injection Product Portfolios and Specifications
13.3.3 Precision Dose Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Precision Dose Main Business Overview
13.3.5 Precision Dose Latest Developments
13.4 CR Double-Crane
13.4.1 CR Double-Crane Company Information
13.4.2 CR Double-Crane Phentolamine Mesylate Injection Product Portfolios and Specifications
13.4.3 CR Double-Crane Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 CR Double-Crane Main Business Overview
13.4.5 CR Double-Crane Latest Developments
13.5 Sichuan Meida Kangjiale Pharmaceutical
13.5.1 Sichuan Meida Kangjiale Pharmaceutical Company Information
13.5.2 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolios and Specifications
13.5.3 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sichuan Meida Kangjiale Pharmaceutical Main Business Overview
13.5.5 Sichuan Meida Kangjiale Pharmaceutical Latest Developments
13.6 Sunflower Pharmaceutical
13.6.1 Sunflower Pharmaceutical Company Information
13.6.2 Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolios and Specifications
13.6.3 Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sunflower Pharmaceutical Main Business Overview
13.6.5 Sunflower Pharmaceutical Latest Developments
13.7 Shanghai Fudan Forward Pharmaceuticals
13.7.1 Shanghai Fudan Forward Pharmaceuticals Company Information
13.7.2 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolios and Specifications
13.7.3 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Fudan Forward Pharmaceuticals Main Business Overview
13.7.5 Shanghai Fudan Forward Pharmaceuticals Latest Developments
13.8 Hainan Poly Pharm
13.8.1 Hainan Poly Pharm Company Information
13.8.2 Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolios and Specifications
13.8.3 Hainan Poly Pharm Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hainan Poly Pharm Main Business Overview
13.8.5 Hainan Poly Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Phentolamine Mesylate Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Phentolamine Mesylate Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Phentolamine Mesylate Injection by Country/Region, 2021, 2025 & 2032
2.2 Phentolamine Mesylate Injection Segment by Type
2.2.1 Intravenous Injection
2.2.2 Intramuscular Injection
2.2.3 Phentolamine Mesylate Injection Sales by Type
2.2.3.1 Global Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Phentolamine Mesylate Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Phentolamine Mesylate Injection Sale Price by Type (2021-2026)
2.3 Phentolamine Mesylate Injection Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Phentolamine Mesylate Injection Sales by Application
2.3.4.1 Global Phentolamine Mesylate Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Phentolamine Mesylate Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Phentolamine Mesylate Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Phentolamine Mesylate Injection Breakdown Data by Company
3.1.1 Global Phentolamine Mesylate Injection Annual Sales by Company (2021-2026)
3.1.2 Global Phentolamine Mesylate Injection Sales Market Share by Company (2021-2026)
3.2 Global Phentolamine Mesylate Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Phentolamine Mesylate Injection Revenue by Company (2021-2026)
3.2.2 Global Phentolamine Mesylate Injection Revenue Market Share by Company (2021-2026)
3.3 Global Phentolamine Mesylate Injection Sale Price by Company
3.4 Key Manufacturers Phentolamine Mesylate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Phentolamine Mesylate Injection Product Location Distribution
3.4.2 Players Phentolamine Mesylate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHENTOLAMINE MESYLATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Phentolamine Mesylate Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Phentolamine Mesylate Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Phentolamine Mesylate Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Phentolamine Mesylate Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Phentolamine Mesylate Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Phentolamine Mesylate Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Phentolamine Mesylate Injection Sales Growth
4.4 APAC Phentolamine Mesylate Injection Sales Growth
4.5 Europe Phentolamine Mesylate Injection Sales Growth
4.6 Middle East & Africa Phentolamine Mesylate Injection Sales Growth
5 AMERICAS
5.1 Americas Phentolamine Mesylate Injection Sales by Country
5.1.1 Americas Phentolamine Mesylate Injection Sales by Country (2021-2026)
5.1.2 Americas Phentolamine Mesylate Injection Revenue by Country (2021-2026)
5.2 Americas Phentolamine Mesylate Injection Sales by Type (2021-2026)
5.3 Americas Phentolamine Mesylate Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phentolamine Mesylate Injection Sales by Region
6.1.1 APAC Phentolamine Mesylate Injection Sales by Region (2021-2026)
6.1.2 APAC Phentolamine Mesylate Injection Revenue by Region (2021-2026)
6.2 APAC Phentolamine Mesylate Injection Sales by Type (2021-2026)
6.3 APAC Phentolamine Mesylate Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Phentolamine Mesylate Injection by Country
7.1.1 Europe Phentolamine Mesylate Injection Sales by Country (2021-2026)
7.1.2 Europe Phentolamine Mesylate Injection Revenue by Country (2021-2026)
7.2 Europe Phentolamine Mesylate Injection Sales by Type (2021-2026)
7.3 Europe Phentolamine Mesylate Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Phentolamine Mesylate Injection by Country
8.1.1 Middle East & Africa Phentolamine Mesylate Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Phentolamine Mesylate Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Phentolamine Mesylate Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Phentolamine Mesylate Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Phentolamine Mesylate Injection
10.3 Manufacturing Process Analysis of Phentolamine Mesylate Injection
10.4 Industry Chain Structure of Phentolamine Mesylate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Phentolamine Mesylate Injection Distributors
11.3 Phentolamine Mesylate Injection Customer
12 WORLD FORECAST REVIEW FOR PHENTOLAMINE MESYLATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Phentolamine Mesylate Injection Market Size Forecast by Region
12.1.1 Global Phentolamine Mesylate Injection Forecast by Region (2027-2032)
12.1.2 Global Phentolamine Mesylate Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Phentolamine Mesylate Injection Forecast by Type (2027-2032)
12.7 Global Phentolamine Mesylate Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Septodont
13.1.1 Septodont Company Information
13.1.2 Septodont Phentolamine Mesylate Injection Product Portfolios and Specifications
13.1.3 Septodont Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Septodont Main Business Overview
13.1.5 Septodont Latest Developments
13.2 Hikma
13.2.1 Hikma Company Information
13.2.2 Hikma Phentolamine Mesylate Injection Product Portfolios and Specifications
13.2.3 Hikma Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Hikma Main Business Overview
13.2.5 Hikma Latest Developments
13.3 Precision Dose
13.3.1 Precision Dose Company Information
13.3.2 Precision Dose Phentolamine Mesylate Injection Product Portfolios and Specifications
13.3.3 Precision Dose Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Precision Dose Main Business Overview
13.3.5 Precision Dose Latest Developments
13.4 CR Double-Crane
13.4.1 CR Double-Crane Company Information
13.4.2 CR Double-Crane Phentolamine Mesylate Injection Product Portfolios and Specifications
13.4.3 CR Double-Crane Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 CR Double-Crane Main Business Overview
13.4.5 CR Double-Crane Latest Developments
13.5 Sichuan Meida Kangjiale Pharmaceutical
13.5.1 Sichuan Meida Kangjiale Pharmaceutical Company Information
13.5.2 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolios and Specifications
13.5.3 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sichuan Meida Kangjiale Pharmaceutical Main Business Overview
13.5.5 Sichuan Meida Kangjiale Pharmaceutical Latest Developments
13.6 Sunflower Pharmaceutical
13.6.1 Sunflower Pharmaceutical Company Information
13.6.2 Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolios and Specifications
13.6.3 Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sunflower Pharmaceutical Main Business Overview
13.6.5 Sunflower Pharmaceutical Latest Developments
13.7 Shanghai Fudan Forward Pharmaceuticals
13.7.1 Shanghai Fudan Forward Pharmaceuticals Company Information
13.7.2 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolios and Specifications
13.7.3 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Fudan Forward Pharmaceuticals Main Business Overview
13.7.5 Shanghai Fudan Forward Pharmaceuticals Latest Developments
13.8 Hainan Poly Pharm
13.8.1 Hainan Poly Pharm Company Information
13.8.2 Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolios and Specifications
13.8.3 Hainan Poly Pharm Phentolamine Mesylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hainan Poly Pharm Main Business Overview
13.8.5 Hainan Poly Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Phentolamine Mesylate Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Phentolamine Mesylate Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intravenous Injection
Table 4. Major Players of Intramuscular Injection
Table 5. Global Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Table 7. Global Phentolamine Mesylate Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Phentolamine Mesylate Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Phentolamine Mesylate Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Phentolamine Mesylate Injection Sale Market Share by Application (2021-2026)
Table 12. Global Phentolamine Mesylate Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Phentolamine Mesylate Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Phentolamine Mesylate Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Phentolamine Mesylate Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Phentolamine Mesylate Injection Sales Market Share by Company (2021-2026)
Table 17. Global Phentolamine Mesylate Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Phentolamine Mesylate Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Phentolamine Mesylate Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Phentolamine Mesylate Injection Producing Area Distribution and Sales Area
Table 21. Players Phentolamine Mesylate Injection Products Offered
Table 22. Phentolamine Mesylate Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Phentolamine Mesylate Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Phentolamine Mesylate Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Phentolamine Mesylate Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Phentolamine Mesylate Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Phentolamine Mesylate Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Phentolamine Mesylate Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Phentolamine Mesylate Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Phentolamine Mesylate Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Phentolamine Mesylate Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Phentolamine Mesylate Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Phentolamine Mesylate Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Phentolamine Mesylate Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Phentolamine Mesylate Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Phentolamine Mesylate Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Phentolamine Mesylate Injection
Table 52. Key Market Challenges & Risks of Phentolamine Mesylate Injection
Table 53. Key Industry Trends of Phentolamine Mesylate Injection
Table 54. Phentolamine Mesylate Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Phentolamine Mesylate Injection Distributors List
Table 57. Phentolamine Mesylate Injection Customer List
Table 58. Global Phentolamine Mesylate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Phentolamine Mesylate Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Phentolamine Mesylate Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Phentolamine Mesylate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Phentolamine Mesylate Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Phentolamine Mesylate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Phentolamine Mesylate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Phentolamine Mesylate Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Phentolamine Mesylate Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Phentolamine Mesylate Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Phentolamine Mesylate Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Septodont Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Septodont Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 74. Septodont Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Septodont Main Business
Table 76. Septodont Latest Developments
Table 77. Hikma Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Hikma Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 79. Hikma Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Hikma Main Business
Table 81. Hikma Latest Developments
Table 82. Precision Dose Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Precision Dose Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 84. Precision Dose Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Precision Dose Main Business
Table 86. Precision Dose Latest Developments
Table 87. CR Double-Crane Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. CR Double-Crane Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 89. CR Double-Crane Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. CR Double-Crane Main Business
Table 91. CR Double-Crane Latest Developments
Table 92. Sichuan Meida Kangjiale Pharmaceutical Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 94. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sichuan Meida Kangjiale Pharmaceutical Main Business
Table 96. Sichuan Meida Kangjiale Pharmaceutical Latest Developments
Table 97. Sunflower Pharmaceutical Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 99. Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Sunflower Pharmaceutical Main Business
Table 101. Sunflower Pharmaceutical Latest Developments
Table 102. Shanghai Fudan Forward Pharmaceuticals Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 104. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Shanghai Fudan Forward Pharmaceuticals Main Business
Table 106. Shanghai Fudan Forward Pharmaceuticals Latest Developments
Table 107. Hainan Poly Pharm Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 109. Hainan Poly Pharm Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Hainan Poly Pharm Main Business
Table 111. Hainan Poly Pharm Latest Developments
Table 1. Phentolamine Mesylate Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Phentolamine Mesylate Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intravenous Injection
Table 4. Major Players of Intramuscular Injection
Table 5. Global Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Table 7. Global Phentolamine Mesylate Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Phentolamine Mesylate Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Phentolamine Mesylate Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Phentolamine Mesylate Injection Sale Market Share by Application (2021-2026)
Table 12. Global Phentolamine Mesylate Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Phentolamine Mesylate Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Phentolamine Mesylate Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Phentolamine Mesylate Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Phentolamine Mesylate Injection Sales Market Share by Company (2021-2026)
Table 17. Global Phentolamine Mesylate Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Phentolamine Mesylate Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Phentolamine Mesylate Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Phentolamine Mesylate Injection Producing Area Distribution and Sales Area
Table 21. Players Phentolamine Mesylate Injection Products Offered
Table 22. Phentolamine Mesylate Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Phentolamine Mesylate Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Phentolamine Mesylate Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Phentolamine Mesylate Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Phentolamine Mesylate Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Phentolamine Mesylate Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Phentolamine Mesylate Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Phentolamine Mesylate Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Phentolamine Mesylate Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Phentolamine Mesylate Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Phentolamine Mesylate Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Phentolamine Mesylate Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Phentolamine Mesylate Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Phentolamine Mesylate Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Phentolamine Mesylate Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Phentolamine Mesylate Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Phentolamine Mesylate Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Phentolamine Mesylate Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Phentolamine Mesylate Injection
Table 52. Key Market Challenges & Risks of Phentolamine Mesylate Injection
Table 53. Key Industry Trends of Phentolamine Mesylate Injection
Table 54. Phentolamine Mesylate Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Phentolamine Mesylate Injection Distributors List
Table 57. Phentolamine Mesylate Injection Customer List
Table 58. Global Phentolamine Mesylate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Phentolamine Mesylate Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Phentolamine Mesylate Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Phentolamine Mesylate Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Phentolamine Mesylate Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Phentolamine Mesylate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Phentolamine Mesylate Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Phentolamine Mesylate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Phentolamine Mesylate Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Phentolamine Mesylate Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Phentolamine Mesylate Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Phentolamine Mesylate Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Septodont Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Septodont Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 74. Septodont Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Septodont Main Business
Table 76. Septodont Latest Developments
Table 77. Hikma Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Hikma Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 79. Hikma Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Hikma Main Business
Table 81. Hikma Latest Developments
Table 82. Precision Dose Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Precision Dose Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 84. Precision Dose Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Precision Dose Main Business
Table 86. Precision Dose Latest Developments
Table 87. CR Double-Crane Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. CR Double-Crane Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 89. CR Double-Crane Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. CR Double-Crane Main Business
Table 91. CR Double-Crane Latest Developments
Table 92. Sichuan Meida Kangjiale Pharmaceutical Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 94. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sichuan Meida Kangjiale Pharmaceutical Main Business
Table 96. Sichuan Meida Kangjiale Pharmaceutical Latest Developments
Table 97. Sunflower Pharmaceutical Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 99. Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Sunflower Pharmaceutical Main Business
Table 101. Sunflower Pharmaceutical Latest Developments
Table 102. Shanghai Fudan Forward Pharmaceuticals Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 104. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Shanghai Fudan Forward Pharmaceuticals Main Business
Table 106. Shanghai Fudan Forward Pharmaceuticals Latest Developments
Table 107. Hainan Poly Pharm Basic Information, Phentolamine Mesylate Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolios and Specifications
Table 109. Hainan Poly Pharm Phentolamine Mesylate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Hainan Poly Pharm Main Business
Table 111. Hainan Poly Pharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Phentolamine Mesylate Injection
Figure 2. Phentolamine Mesylate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Phentolamine Mesylate Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Phentolamine Mesylate Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Phentolamine Mesylate Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Phentolamine Mesylate Injection Sales Market Share by Country/Region (2025)
Figure 10. Phentolamine Mesylate Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intravenous Injection
Figure 12. Product Picture of Intramuscular Injection
Figure 13. Global Phentolamine Mesylate Injection Sales Market Share by Type in 2026
Figure 14. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2021-2026)
Figure 15. Phentolamine Mesylate Injection Consumed in Hospital and Clinic
Figure 16. Global Phentolamine Mesylate Injection Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Phentolamine Mesylate Injection Consumed in Pharmacy
Figure 18. Global Phentolamine Mesylate Injection Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Phentolamine Mesylate Injection Consumed in Other
Figure 20. Global Phentolamine Mesylate Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Phentolamine Mesylate Injection Sale Market Share by Application (2025)
Figure 22. Global Phentolamine Mesylate Injection Revenue Market Share by Application in 2026
Figure 23. Phentolamine Mesylate Injection Sales by Company in 2026 (K Units)
Figure 24. Global Phentolamine Mesylate Injection Sales Market Share by Company in 2026
Figure 25. Phentolamine Mesylate Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Phentolamine Mesylate Injection Revenue Market Share by Company in 2026
Figure 27. Global Phentolamine Mesylate Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Phentolamine Mesylate Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Phentolamine Mesylate Injection Sales 2021-2026 (K Units)
Figure 30. Americas Phentolamine Mesylate Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Phentolamine Mesylate Injection Sales 2021-2026 (K Units)
Figure 32. APAC Phentolamine Mesylate Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Phentolamine Mesylate Injection Sales 2021-2026 (K Units)
Figure 34. Europe Phentolamine Mesylate Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Phentolamine Mesylate Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Phentolamine Mesylate Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Phentolamine Mesylate Injection Sales Market Share by Country in 2026
Figure 38. Americas Phentolamine Mesylate Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Phentolamine Mesylate Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Phentolamine Mesylate Injection Sales Market Share by Region in 2026
Figure 46. APAC Phentolamine Mesylate Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Phentolamine Mesylate Injection Sales Market Share by Application (2021-2026)
Figure 49. China Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Phentolamine Mesylate Injection Sales Market Share by Country in 2026
Figure 57. Europe Phentolamine Mesylate Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Phentolamine Mesylate Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Phentolamine Mesylate Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Phentolamine Mesylate Injection in 2026
Figure 74. Manufacturing Process Analysis of Phentolamine Mesylate Injection
Figure 75. Industry Chain Structure of Phentolamine Mesylate Injection
Figure 76. Channels of Distribution
Figure 77. Global Phentolamine Mesylate Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Phentolamine Mesylate Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Phentolamine Mesylate Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Phentolamine Mesylate Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Phentolamine Mesylate Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Phentolamine Mesylate Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Phentolamine Mesylate Injection
Figure 2. Phentolamine Mesylate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Phentolamine Mesylate Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Phentolamine Mesylate Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Phentolamine Mesylate Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Phentolamine Mesylate Injection Sales Market Share by Country/Region (2025)
Figure 10. Phentolamine Mesylate Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intravenous Injection
Figure 12. Product Picture of Intramuscular Injection
Figure 13. Global Phentolamine Mesylate Injection Sales Market Share by Type in 2026
Figure 14. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2021-2026)
Figure 15. Phentolamine Mesylate Injection Consumed in Hospital and Clinic
Figure 16. Global Phentolamine Mesylate Injection Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Phentolamine Mesylate Injection Consumed in Pharmacy
Figure 18. Global Phentolamine Mesylate Injection Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Phentolamine Mesylate Injection Consumed in Other
Figure 20. Global Phentolamine Mesylate Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Phentolamine Mesylate Injection Sale Market Share by Application (2025)
Figure 22. Global Phentolamine Mesylate Injection Revenue Market Share by Application in 2026
Figure 23. Phentolamine Mesylate Injection Sales by Company in 2026 (K Units)
Figure 24. Global Phentolamine Mesylate Injection Sales Market Share by Company in 2026
Figure 25. Phentolamine Mesylate Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Phentolamine Mesylate Injection Revenue Market Share by Company in 2026
Figure 27. Global Phentolamine Mesylate Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Phentolamine Mesylate Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Phentolamine Mesylate Injection Sales 2021-2026 (K Units)
Figure 30. Americas Phentolamine Mesylate Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Phentolamine Mesylate Injection Sales 2021-2026 (K Units)
Figure 32. APAC Phentolamine Mesylate Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Phentolamine Mesylate Injection Sales 2021-2026 (K Units)
Figure 34. Europe Phentolamine Mesylate Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Phentolamine Mesylate Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Phentolamine Mesylate Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Phentolamine Mesylate Injection Sales Market Share by Country in 2026
Figure 38. Americas Phentolamine Mesylate Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Phentolamine Mesylate Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Phentolamine Mesylate Injection Sales Market Share by Region in 2026
Figure 46. APAC Phentolamine Mesylate Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Phentolamine Mesylate Injection Sales Market Share by Application (2021-2026)
Figure 49. China Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Phentolamine Mesylate Injection Sales Market Share by Country in 2026
Figure 57. Europe Phentolamine Mesylate Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Phentolamine Mesylate Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Phentolamine Mesylate Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Phentolamine Mesylate Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Phentolamine Mesylate Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Phentolamine Mesylate Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Phentolamine Mesylate Injection in 2026
Figure 74. Manufacturing Process Analysis of Phentolamine Mesylate Injection
Figure 75. Industry Chain Structure of Phentolamine Mesylate Injection
Figure 76. Channels of Distribution
Figure 77. Global Phentolamine Mesylate Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Phentolamine Mesylate Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Phentolamine Mesylate Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Phentolamine Mesylate Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Phentolamine Mesylate Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Phentolamine Mesylate Injection Revenue Market Share Forecast by Application (2027-2032)
